Overview
atai Life Sciences is a publicly listed biotech platform company building a portfolio of clinical-stage mental health companies developing psychedelic and non-psychedelic treatments for depression, PTSD, anxiety, and addiction. Their subsidiaries include programs using psilocybin, DMT, MDMA, and novel compounds.
More in Psychedelics
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 · Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 · Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 · Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
Company details
Category
🍄 Psychedelics
Location
Berlin, Germany
Funding
Public · NASDAQ: ATAI
Website
www.atai.lifeListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →